Companies: 10,795·Total market cap: $144.5T
Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc.

OTLKNASDAQHealthcare● Active
$0.72
$-0.05(-7.04%)
Market Cap$29703369
P/E Ratio
52W High$3.39
52W Low$0.161

Outlook Therapeutics, Inc.(OTLK)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · OTLK · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-092024-092023-092022-092021-09
Revenue
Revenue$1.41M$0.00M$0.00M$0.00M$0.00M
Cost of Revenue$0.76M$0.11M$0.04M$0.20M$0.26M
Gross Profit$0.66M($0.11M)($0.04M)($0.20M)($0.26M)
Gross Margin %(computed)46.49%
Operating Expenses
R&D Expenses$27180640.00M$41.76M$26.45M$42.33M$38.96M
G&A Expenses$39.94M$29.94M$26.67M$20.74M$12.77M
Total Operating Expenses$67.72M$71.70M$53.13M$62.87M$51.73M
Operating Income($67.06M)($71.70M)($53.13M)($63.07M)($51.73M)
Operating Margin %(computed)
Interest Income$0.09M$0.91M$0.00M$0.00M$0.00M
Interest Expense$0.28M$3.16M$1.56M$1.49M$0.94M
Income Before Tax($63.98M)($75.36M)($58.98M)($66.05M)($53.16M)
Income Tax Expense($1.55M)$0.00M$0.00M$0.00M$0.00M
Net Income($62.42M)($75.37M)($58.98M)($66.05M)($53.16M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.79$-4.06$-4.72$-6.23$-6.96
Wtd Avg Shares34.80M18.55M12.51M10.60M7.63M
EBITDA($63.58M)($72.09M)($57.38M)($64.36M)($51.51M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Outlook Therapeutics, Inc.

关于Outlook Therapeutics, Inc.(OTLK)损益表

Outlook Therapeutics, Inc.(OTLK)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,OTLK实现营收$0.00B,毛利润$0.00B(毛利率46.49%),净利润($0.06B)(净利率-4416.22%)。

常见问题

OTLK · 4 问

Outlook Therapeutics, Inc.(OTLK)2025财年营收为$0.00B,同比up—%。

OTLK revenueOTLK salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09